C62 - Mild Cognitive Impairment: Implications for Clinicians

Event Time: Monday April 24, 2017 7:00 am to 9:00 am
Topic(s): Aging, Dementia, Cognitive, and Behavioral Neurology
Director(s): David Gill MD, FAAN
Description: The diagnosis of mild cognitive impairment (MCI) often represents prodromal Alzheimer's disease or other dementia. However, diagnosis, prediction of outcome, and treatment of patients with mild cognitive impairment presents many challenges. Faculty will address the diagnosis, pathophysiology, role of biomarkers, and treatment of mild cognitive impairment. The upcoming revision of the AAN Practice Parameter for MCI will be reviewed and a number of cases will be presented to illustrate controversies and management issues.
Completion Message: Participants should be able to understand the basic biology of MCI and be familiar with the recommended diagnostic strategy, appropriate use of biomarkers, and management of patients with MCI.
CME Credits: 2
Core Competencies: Medical Knowledge, Patient Care, Practice-Based Learning and Improvement

Ready to register for the 2018 AAN Annual Meeting?

Register Now

Related Courses